Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study-Reference-Cited by-同舟云学术

Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study

Published:2010-07-22 Issue:15 Volume:16 Page:3976-3987
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Katz Ruth L.,He Weigong,Khanna Abha,Fernandez Ricardo L.,Zaidi Tanweer M.,Krebs Matthew,Caraway Nancy P.,Zhang Hua-Zhong,Jiang Feng,Spitz Margaret R.,Blowers David P.,Jimenez Carlos A.,Mehran Reza J.,Swisher Stephen G.,Roth Jack A.,Morris Jeffrey S.,Etzel Carol J.,El-Zein Randa

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Lightweight Deep Learning Framework for Identifying Circulating Genetically Abnormal Cells in Four-color Fluorescence in Situ Hybridization Images;2024 5th International Conference on Computer Vision, Image and Deep Learning (CVIDL);2024-04-19

2. The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules;BMC Pulmonary Medicine;2023-06-05

3. Criteria for lung cancer screening and standardized management in China;Chinese Medical Journal;2023-06-02

4. An Early Lung Cancer Diagnosis Model for Non-Smokers Incorporating Artificial Intelligence and Liquid Biopsy;2023

5. Diagnostic value of tumor associated autoantibody panel in early detection of lung cancer in Chinese population: Protocol for a prospective, observational, and multicenter clinical trial;Clinical eHealth;2022-12